These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9850535)

  • 1. New approaches to the development of virus vaccines for veterinary use.
    Yamanouchi K; Barrett T; Kai C
    Rev Sci Tech; 1998 Dec; 17(3):641-53. PubMed ID: 9850535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant viral vector vaccines for the veterinary use.
    Yokoyama N; Maeda K; Mikami T
    J Vet Med Sci; 1997 May; 59(5):311-22. PubMed ID: 9192350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
    Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant viruses as vaccines against viral diseases.
    Souza AP; Haut L; Reyes-Sandoval A; Pinto AR
    Braz J Med Biol Res; 2005 Apr; 38(4):509-22. PubMed ID: 15962176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poxvirus recombinant vaccines.
    Paoletti E
    Ann N Y Acad Sci; 1990; 590():309-25. PubMed ID: 2198832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of pox virus vectors to vaccination: an update.
    Paoletti E
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11349-53. PubMed ID: 8876138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens.
    Kamel M; El-Sayed A
    Virus Res; 2019 Sep; 270():197648. PubMed ID: 31279828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
    Ramezanpour B; Haan I; Osterhaus A; Claassen E
    Vaccine; 2016 Dec; 34(50):6436-6448. PubMed ID: 28029542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poxvirus vectors: cytoplasmic expression of transferred genes.
    Moss B
    Curr Opin Genet Dev; 1993 Feb; 3(1):86-90. PubMed ID: 8453278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.
    Xing Z; Santosuosso M; McCormick S; Yang TC; Millar J; Hitt M; Wan Y; Bramson J; Vordermeier HM
    Curr Gene Ther; 2005 Oct; 5(5):485-92. PubMed ID: 16250889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia and other poxvirus expression vectors.
    Moss B
    Curr Opin Biotechnol; 1992 Oct; 3(5):518-22. PubMed ID: 1368937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabies vaccine. Developments employing molecular biology methods.
    Paolazzi CC; Pérez O; De Filippo J
    Mol Biotechnol; 1999 Apr; 11(2):137-47. PubMed ID: 10464768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
    Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
    Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative-strand RNA viruses: genetic engineering and applications.
    Palese P; Zheng H; Engelhardt OG; Pleschka S; García-Sastre A
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11354-8. PubMed ID: 8876139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in viral vectors in veterinary vaccinology.
    Baron MD; Iqbal M; Nair V
    Curr Opin Virol; 2018 Apr; 29():1-7. PubMed ID: 29477122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative-Strand RNA Virus-Vectored Vaccines.
    Murr M; Mettenleiter T
    Methods Mol Biol; 2024; 2786():51-87. PubMed ID: 38814390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.
    Moss B
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11341-8. PubMed ID: 8876137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.